XML 22 R11.htm IDEA: XBRL DOCUMENT  v2.3.0.11
SEGMENT INFORMATION
9 Months Ended
Jun. 30, 2011
SEGMENT INFORMATION
6.
SEGMENT INFORMATION
 
We operate in two principal segments - research services and research products. Our Services segment provides research and development support on a contract basis directly to pharmaceutical companies. Our Products segment provides liquid chromatography, electrochemical and physiological monitoring products to pharmaceutical companies, universities, government research centers and medical research institutions.  Our accounting policies in these segments are the same as those described in the summary of significant accounting policies found in Note 2 to Consolidated Financial Statements in our annual report on Form 10-K for the year ended September 30, 2010.

   
Three Months Ended
June 30,
   
Nine Months Ended
June 30,
 
   
2011
   
2010
   
2011
   
2010
 
Revenue:
                       
Service
  $ 6,737     $ 6,034     $ 19,326     $ 16,092  
Product
    1,741       2,030       5,665       5,284  
    $ 8,478     $ 8,064     $ 24,991     $ 21,376  
                                 
Operating income (loss):
                               
Service
  $ 376     $ 227     $ 1,088     $ (2,320 )
Product
    105       331       581       351  
    $ 481     $ 558     $ 1,669     $ (1,969 )